Answer
The selected product is licensed from age 3 years for recurrent or progressive malignant glioma. Experience in children is limited, and safety below age 3 has not been established.
Sources for this answer
- Temodal Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.